Papers

2

Total Citations

72

H-Index

2

About

Francesco Ghetti’s research lies at the intersection of biophotonics and microbiology, with a primary focus on combatting antimicrobial resistance through innovative light-based therapies. His major contributions center on the spectroscopic characterization and fluorescence imaging of endogenous porphyrins in *Helicobacter pylori*, a pathogen linked to severe gastric diseases including cancer. By exploiting these naturally occurring photosensitizers, Ghetti has pioneered non-pharmacological approaches to bacterial inactivation. His 2017 study on porphyrin fluorescence imaging (43 citations) established a foundation for diagnostic applications, while his 2020 work on a novel LED-based photoinactivation device (29 citations) directly addresses the global crisis of antibiotic resistance. This device offers a promising alternative to conventional therapy for *H. pylori* infections, which increasingly fail due to multidrug resistance. Ghetti’s work is notable for bridging fundamental photophysics with translational medical devices, demonstrating how spectroscopic insights can lead to practical clinical tools. His research continues to inspire new strategies for infection control without antibiotics, making him a key figure in the emerging field of antimicrobial photodynamic therapy.

Research Focus

Key Achievements

2
H-Index
2
Papers
72
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Spectroscopic characterization and fluorescence imaging of Helicobacter pylori endogenous porphyrins
43 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Scuola Normale Superiore, National Enterprise for NanoScience and NanoTechnology

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago